[1]韩鹏勃,蒋 锋△,刘 柱,等.加味身痛逐瘀汤调控Wnt/β-catenin信号通路对大鼠骨质疏松症的防治作用*[J].陕西中医,2020,(6):715-719.[doi:DOI:10.3969/j.issn.10007369.2020.06.005]
　HAN Pengbo,JIANG Feng,LIU Zhu,et al.Therapeutic effect of Jiawei Shentong Zhuyu decoction on osteoporosis related to regulating Wnt/β-catenin signaling pathway in rats[J].,2020,(6):715-719.[doi:DOI:10.3969/j.issn.10007369.2020.06.005]
点击复制

加味身痛逐瘀汤调控Wnt/β-catenin信号通路对大鼠骨质疏松症的防治作用*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年6期
页码:
715-719
栏目:
基础研究
出版日期:
2020-06-01

文章信息/Info

Title:
Therapeutic effect of Jiawei Shentong Zhuyu decoction on osteoporosis related to regulating Wnt/β-catenin signaling pathway in rats
作者:
韩鹏勃1; 蒋 锋2△; 刘 柱1; 姚亚波1
1.西安医学院第二附属医院(西安 710038); 2.陕西省友谊医院(西安 710068)
Author(s):
HAN Pengbo; JIANG Feng; LIU Zhu; et al.
Second Affiliated Hospital of Xi'an Medical College(Xi'an 710038)
关键词:
加味身痛逐瘀汤;  骨质疏松;  Wnt/β-catenin 信号通路;  骨密度
Keywords:
Jiawei Shentong Zhuyu decoction;  Osteoporosis;  Wnt/β-catenin signaling pathway;  Bone density
分类号:
R274
DOI:
DOI:10.3969/j.issn.10007369.2020.06.005
文献标志码:
A
摘要:
目的:探讨加味身痛逐瘀汤防治去卵巢大鼠骨质疏松症(OP)的疗效及其可能作用机制。方法:将60只SD大鼠,体重(245±25)g,随机分为假手术组、模型组、戊酸雌二醇组、加味身痛逐瘀汤高、中、低剂量组,每组10只。利用双侧卵巢切除法制备大鼠骨质疏松模型,手术模型制备成功后,戊酸雌二醇组大鼠给予戊酸雌二醇(剂量为 0.09 μg/g)灌胃; 加味身痛逐瘀汤治疗组大鼠给予加味身痛逐瘀汤(剂量为 32、16、8 g/kg)灌胃; 假手术组和模型对照组大鼠给予等体积蒸馏水灌胃,连续灌胃给药2个月。利用双能 X 线骨密度检测仪、HE染色法及Western blot分别测定骨密度,观察骨组织病理形态变化,分析大鼠股骨组织中Wnt、Wnt1、β-catenin、cyclin D1蛋白表达情况。结果:与假手术组比较,模型对照组骨密度明显降低(P<0.05),骨微结构遭到严重破坏,股骨组织中Wnt、Wnt1、β-catenin、cyclin D1蛋白的表达量显著降低(P<0.05)。与模型对照组相比,戊酸雌二醇组、加味身痛逐瘀汤高、中、低剂量组骨密度显著升高(P<0.05),骨微结构明显改善,股骨组织中Wnt、Wnt1、β-catenin、cyclin D1蛋白的表达量显著升高(P<0.05),且加味身痛逐瘀汤高剂量组和戊酸雌二醇组对骨密度及蛋白表达量的影响最为显著。结论:加味身痛逐瘀汤可能通过调节 Wnt/β-catenin 信号通路提高骨质疏松症大鼠的骨密度以及改善骨组织形态,从而发挥抗骨质疏松的作用。
Abstract:
Objective:To investigate the effect and possible mechanism of Jiawei Shentong Zhuyu decoction on osteoporosis(OP)in ovariectomy rats.Methods:60 SD rats,weighing(245±25)g,were randomly divided into sham operation group,model group,estradiol valerate group,and the high,medium and low dose groups of Jiawei Shentong Zhuyu decoction,with 10 rats in each group.The rat osteoporosis model was prepared by bilateral ovariectomy.After the successful preparation of the surgical model,the rats in the estradiol valerate group were given estradiol valerate(0.09 μg /g)by gavage.The rats in the treatment group were given Jiawei Shentong Zhuyu decoction(32,16,8 g/kg)by gavage.Rats in sham operation group and model control group were gavaged with distilled water of equal volume for 2 months.Dual-energy X-ray bone mineral density detector,HE staining method and Western blot were used to determine the bone mineral density,observe the pathological morphological changes of bone tissue,and analyze the expression of Wnt,Wnt1,β-catenin and cyclin D1 proteins in rat femoral tissue.Results: Compared with sham operation group,the bone density of the model control group was significantly decreased(P<0.05),the bone microstructure was seriously damaged and the expression of Wnt,Wnt1,β-catenin,cyclin D1 protein in femoral tissue was significantly decreased(P<0.05).Compared with the model control group,the bone density increased significantly(P<0.05),the bone microstructure was obviously improved,and the expression of Wnt,Wnt1,β-catenin and cyclin D1 in the femoral tissue was significantly increased(P<0.05)in the estradiol valerate group and Jiawei Shentong Zhuyu decoction high,middle and low dose groups,and the effects of Jiawei Shentong Zhuyu decoction high-dose group and estradiol valerate on bone density and protein expression were the most significant.Conclusion: Jiawei Shentong Zhuyu decoction may play an anti-osteoporosis effect by regulating Wnt/β-catenin signaling pathway to improve bone density and improve bone morphology in osteoporosis rats.

参考文献/References:

[1] Kanis JA.Osteoporosis[J].Endocrinology & Metabolism Clinics of North America,1997,26(4):913-936.
[2] Harvey N,Dennison E,Cooper C.Osteoporosis:impact on health and economics[J].Nature Reviews Rheumatology,2010,6(2):99-105.
[3] 沈 蓝,韩雨杉,赵宏斌,等.中药治疗骨质疏松性骨折中Wnt/β-catenin通路的研究进展[J].中华中医药杂志,2015,35(7):192-194.
[4] 袁菱梅,李艳明,陈丽妹,等.电针结合加味身痛逐瘀汤治疗原发性骨质疏松症40例[J].针灸临床杂志,2015,33(8):12-14.
[5] 姚艺豪.加味身痛逐瘀汤治疗老年腰椎间盘突出症伴腰椎骨质疏松患者50例疗效观察[J].中国民族民间医药,2012,21(11):78-79.
[6] 陈鲁峰,王庆敏,高建平,等.中药治疗老年骨质疏松性椎体压缩性骨折临床观察[J].光明中医,2019,34(1):57-59.
[7] 熊燕琴,周 筠,雷 涛.骨代谢信号通路的研究进展[J].中国骨质疏松杂志,2014,30(2):200-204.
[8] Rossini M,Gatti A.Involvement of Wnt/beta-catenin signaling in the treatment of osteoporosis[J].Calcified Tissue International,2013,93(2):121-132.
[9] Xia B,Xu B,Sun Y,et al.The effects of Liuwei Dihuang on canonical Wnt/β-catenin signaling pathway in osteoporosis[J].Journal of Ethnopharmacology,2014,153(1):133-141.
[10] Nichols DL,Bonnick SL,Sanborn CF.Bone health and osteoporosis[J].Clinics in Sports Medicine,2000,19(2):233-249.
[11] Chapurlat RD,Confavreux CB.Novel biological markers of bone:from bone metabolism to bone physiology[J].Rheumatology,2016,55(10):1714-1725.
[12] Leder BZ.Parathyroid hormone and parathyroid hormone-related protein analogs in osteoporosis therapy[J].Current Osteoporosis Reports,2017,15(2):110-119.
[13] 刘 晨,李兴勇,姚兴璋,等.绝经后骨质疏松症的流行病学概况及发病机制研究进展[J].中医正骨,2018,30(3):52-55.
[14] 马远征,王以朋,刘 强,等.中国老年骨质疏松症诊疗指南(2018)[J].中国骨质疏松杂志,2018,24(12):1541-1567.
[15] 邓 昶,周明旺,付志斌,等.骨质疏松症的中医病因病机及其治疗进展[J].中国骨质疏松杂志,2017,23(8):1105-1111.
[16] 邓中甲.方剂学[M].北京:中国中医药出版社,2003:239.
[17] 眭承志.骨碎补总黄酮治疗骨质疏松症作用机理实验研究进展[J].中华中医药学刊,2010,30(6):156-158.
[18] 吕 慧,李秀芳,李玛琳.中药促进骨质疏松性骨折愈合的作用及机制研究进展[J].云南中医学院学报,2012,35(3):66-70.
[19] 韩学明,李 威,孙忠良.绝经后骨质疏松症患者血清CEACAM1、β-catenin的变化及其与骨密度的关系[J].山东医药,2017,38(29):53-55.
[20] 沈 霖,马 陈,帅 波,等.青娥丸对绝经后骨质疏松症患者β-catenin和DKK-1表达水平的影响[J].中西医结合研究,2016,8(6):281-284.
[21] 成 鹏,白银亮,胡彩莉,等.黄芪甲苷通过调控FoxO3a/Wnt2/β-catenin通路抑制去卵巢大鼠骨质疏松的作用[J].中国实验方剂学杂志,2018,24(15):161-166.

相似文献/References:

[1]齐兵献,樊成虎△,唐晓栋,等.加味身痛逐瘀汤对多节段脊髓性颈椎病经后路〖JZ〗单开门术后轴性症状改善的临床研究*[J].陕西中医,2020,(1):42.
[2]白曼莫,王炳南,禹志军,等.固脊通督方辅助治疗老年骨质疏松胸腰椎压缩性骨折疗效及对患者血清Leptin、PΙNP水平的影响*[J].陕西中医,2020,(10):1449.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.030]
[3]龚绍芹,刘绪荣△,张亚婷.补肾健脾壮骨方预防卵巢低反应后骨质疏松效果及相关机制研究*[J].陕西中医,2020,(12):1712.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.008]
[4]刘孟娇,孟庆良,崔家康,等.名中医孟庆良从“骨肉不相亲”辨治类风湿肌少症合并骨质疏松症经验[J].陕西中医,2024,(11):1538.[doi:DOI:10.3969/j.issn.1000-7369.2024.11.021]

备注/Memo

备注/Memo:
*陕西省科技厅自然科学基础研究一般项目(2017JM8146)
更新日期/Last Update: 2020-06-09